Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
Want to see NEUP full AI Analyst Report?
Neuphoria Therapeutics (NEUP) Ownership Overview
16.20% Insiders
0.51% Mutual Funds
25.39% Other Institutional Investors
5.92% ETFs
51.98% Public Companies and
Individual Investors
The ownership structure of Neuphoria Therapeutics (NEUP) stock is a mix of institutional, retail, and individual investors. Approximately 31.82% of the company’s stock is owned by Institutional Investors, 16.20% is owned by Insiders, and 51.98% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Oct 23, 2025 | xxxxxxxxxxxxx | $3278634 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 875,328 | Insider | 16.20% | 4,796,797 | |
| 221,231 | Institution | 4.09% | 1,212,346 | |
| 98,516 | Institution | 1.82% | 539,868 | |
| 16,600 | Institution | 0.31% | 90,968 | |
| 11,072 | Institution | 0.20% | 60,675 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,600 | Institution | 0.31% | 90,968 | |
| 11,072 | Institution | 0.20% | 60,675 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 221,231 | Institution | 4.09% | 1,090,669 | |
| 63,534 | Institution | 1.18% | 258,583 | |
| 34,982 | Institution | 0.65% | 142,377 |
FAQ
Who Owns Neuphoria Therapeutics (NEUP)?
According to the latest TipRanks data, approximately 25.39% of the company's stock is held by institutional investors, 16.20% is held by insiders, and 51.98% is held by retail investors.
What percentage of Neuphoria Therapeutics (NEUP) stock is held by institutional investors?
According to the latest TipRanks data, approximately 25.39% of Neuphoria Therapeutics (NEUP) stock is held by institutional investors.
What percentage of Neuphoria Therapeutics (NEUP) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.98% of Neuphoria Therapeutics (NEUP) stock is held by retail investors.
Who owns the most shares of Neuphoria Therapeutics (NEUP)?
Lynx1 Capital Management LP owns the most shares of Neuphoria Therapeutics (NEUP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.